Get the Stockscreener App
3.915
6.90%
-0.285
Minerva Neurosciences Inc stock is traded at $3.915, with a volume of 105.13K.
It is down -6.90% in the last 24 hours and up +86.19% over the past month.
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
See More
Previous Close:
$4.20
Open:
$4.15
24h Volume:
105.13K
Relative Volume:
0.04
Market Cap:
$27.13M
Revenue:
-
Net Income/Loss:
$-33.65M
P/E Ratio:
-0.8798
EPS:
-4.45
Net Cash Flow:
$-20.83M
1W Performance:
-13.69%
1M Performance:
+86.19%
6M Performance:
+130.00%
1Y Performance:
+49.24%
1-Day Range:
$3.85
$4.35
1-Week Range:
$3.85
$4.80
52-Week Range:
$1.15
$12.46
Minerva Neurosciences Inc Stock (NERV) Company Profile
Name
Minerva Neurosciences Inc
Sector
Industry
Phone
617-600-7373
Address
1601 TRAPELO ROAD, WALTHAM, MA
Compare NERV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NERV
Minerva Neurosciences Inc
|
3.88 | 29.37M | 0 | -33.65M | -20.83M | -4.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.52 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.42 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.79 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.21 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.05 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Minerva Neurosciences Inc Stock (NERV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-08-20 | Reiterated | H.C. Wainwright | Buy |
| May-14-20 | Initiated | BTIG Research | Buy |
| Oct-02-19 | Reiterated | Chardan Capital Markets | Buy |
| Sep-25-19 | Initiated | Chardan Capital Markets | Buy |
| Sep-18-19 | Initiated | William Blair | Outperform |
| May-31-19 | Initiated | H.C. Wainwright | Buy |
| Sep-01-17 | Initiated | Citigroup | Buy |
| Mar-06-17 | Resumed | Jefferies | Buy |
| May-12-16 | Resumed | Jefferies | Buy |
View All
Minerva Neurosciences Inc Stock (NERV) Latest News
Is Minerva Neurosciences Inc. (4MNA) stock positioned for secular growthJuly 2025 Spike Watch & Low Risk High Win Rate Stock Picks - newser.com
Visualizing Minerva Neurosciences Inc. stock with heatmaps2025 Bull vs Bear & Daily Growth Stock Investment Tips - newser.com
How buybacks impact Minerva Neurosciences Inc. stock valueMarket Weekly Review & AI Powered Buy/Sell Recommendations - newser.com
Using Ichimoku Cloud for Minerva Neurosciences Inc. technicalsMarket Volume Summary & Entry and Exit Point Strategies - newser.com
Why Minerva Neurosciences Inc. stock is seen as undervaluedJuly 2025 Closing Moves & Fast Exit/Entry Strategy Plans - newser.com
Will Minerva Neurosciences Inc. stock continue upward momentumMarket Performance Report & Free Real-Time Volume Trigger Notifications - newser.com
Published on: 2025-11-03 04:45:50 - newser.com
Will Minerva Neurosciences Inc. stock sustain high P E ratiosJuly 2025 Summary & Daily Technical Forecast Reports - newser.com
Will earnings trigger a reversal in Minerva Neurosciences Inc.2025 Big Picture & Fast Gain Swing Alerts - newser.com
Multi asset correlation models including Minerva Neurosciences Inc.Earnings Trend Report & Capital Efficient Trade Techniques - newser.com
Real time scanner hits for Minerva Neurosciences Inc. explainedWeekly Trade Recap & Low Risk Profit Maximizing Plans - newser.com
Is Minerva Neurosciences Inc. stock vulnerable to regulatory risksEarnings Performance Report & Weekly Setup with High ROI Potential - newser.com
Will Minerva Neurosciences Inc. (4MNA) stock outperform global peersQuarterly Earnings Summary & Daily Oversold Bounce Ideas - newser.com
Technical analysis overview for Minerva Neurosciences Inc. stockTrade Risk Summary & Short-Term High Return Ideas - newser.com
Is Minerva Neurosciences Inc. stock overvalued by current metricsJuly 2025 Closing Moves & Technical Pattern Recognition Alerts - newser.com
Volume spikes in Minerva Neurosciences Inc. stock – what they meanJuly 2025 Summary & Real-Time Market Sentiment Reports - newser.com
Is Minerva Neurosciences Inc. stock attractive for income investorsJuly 2025 Market Mood & Low Drawdown Momentum Ideas - newser.com
Automated trading signals detected on Minerva Neurosciences Inc.Treasury Yields & Technical Analysis for Trade Confirmation - newser.com
Combining machine learning predictions for Minerva Neurosciences Inc.Swing Trade & Daily Price Action Insights - newser.com
Will Minerva Neurosciences Inc. stock deliver shareholder valueMarket Performance Recap & AI Driven Stock Price Forecasts - newser.com
Analyzing net buyer seller activity in Minerva Neurosciences Inc.GDP Growth & Pattern Based Trade Signal System - newser.com
Will Minerva Neurosciences Inc. stock keep outperforming rivalsMarket Performance Report & Daily Risk Controlled Trade Plans - newser.com
Does Minerva Neurosciences Inc. stock trade at a discount to peersMarket Trend Review & Smart Allocation Stock Reports - newser.com
How interest rate cuts could boost Minerva Neurosciences Inc. stockProfit Target & Risk Managed Investment Strategies - newser.com
What to do if you’re stuck in Minerva Neurosciences Inc.Weekly Stock Recap & Free Expert Verified Stock Movement Alerts - newser.com
Will Minerva Neurosciences Inc. (4MNA) stock extend growth story2025 Dividend Review & Fast Entry Momentum Alerts - newser.com
Visual analytics tools that track Minerva Neurosciences Inc. performanceEntry Point & Safe Capital Investment Plans - newser.com
Heatmap analysis for Minerva Neurosciences Inc. and competitorsTrade Risk Report & Free Expert Approved Momentum Trade Ideas - newser.com
Minerva Neurosciences Inc. recovery potential after sell offJuly 2025 Breakouts & Daily Technical Stock Forecast Reports - newser.com
Why Minerva Neurosciences Inc. stock is considered a top pickWeekly Risk Summary & Daily Profit Focused Screening - newser.com
Minerva Neurosciences Inc Stock (NERV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):